
TEPADINA® (thiotepa) for Haematopoietic Stem Cell Transplantation is now approved in Singapore
AxxessBio is pleased to announce that Health Sciences Authority (HSA) Singapore has granted the registration rights to supply TEPADINA® (thiotepa) 100mg and TEPADINA® (thiotepa) 15mg with the following indications: With or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in